Content Type: Research Publications

Implications of Medicare Negotiation and Most-Favored-Nation Pricing for Cancer Medicine Costs

May 4, 2026

Using Regression Discontinuity in Time to Strengthen Real-World Evidence: A Case Study in Lung Cancer

May 1, 2026

Prescription Drugs Affected by an Expanded Rare Disease Carve-Out from Medicare Price Negotiation

April 28, 2026

Inflation Reduction Act Changes to Part D Plan Design: Lower Premiums, Higher Deductibles, and Some Smaller Formularies

April 8, 2026

Industry Payments and Prescribing of Brand-Name Multiple Sclerosis Medications in Medicare

April 8, 2026

Out-of-Pocket Spending for Insulin by Medicare Beneficiaries After Monthly Caps

April 8, 2026

Litigating Authority for the FDA

April 8, 2026

Using Prescription Medication Utilization Trends to Evaluate Health System Resilience and Inform Future Emergency Preparedness

April 8, 2026

Priority Without Progress: The FDA’s Neglected Tropical Disease Voucher Program After 18 Years

April 8, 2026

Conflicts of Interest in United States Food and Drug Administration Advisory Committees: A Systematic Literature Review

April 8, 2026

Risk of Neutropenia-Related Hospitalisation Among Clozapine Initiators

April 8, 2026

List Price Reductions Among Brand-Name ICS-LABA Inhalers in 2024 Were Associated With Increased Generic Uptake

April 8, 2026